Michelle Rengarajan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Listeria monocytogenes | 3 | 2020 | 250 | 0.890 |
Why?
|
| Listeriosis | 1 | 2020 | 149 | 0.680 |
Why?
|
| Bacterial Adhesion | 1 | 2020 | 316 | 0.660 |
Why?
|
| Fetal Proteins | 1 | 2016 | 94 | 0.550 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1477 | 0.390 |
Why?
|
| Phagocytosis | 1 | 2016 | 1539 | 0.370 |
Why?
|
| Melanoma | 2 | 2022 | 5510 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5751 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5853 | 0.190 |
Why?
|
| Proteins | 1 | 2016 | 6103 | 0.190 |
Why?
|
| Thyroiditis | 1 | 2021 | 85 | 0.190 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 8863 | 0.190 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13102 | 0.160 |
Why?
|
| alpha Catenin | 1 | 2017 | 38 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
| Fatigue | 1 | 2022 | 1531 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2022 | 1373 | 0.110 |
Why?
|
| Cadherins | 1 | 2017 | 907 | 0.110 |
Why?
|
| Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2020 | 1786 | 0.090 |
Why?
|
| Weight Loss | 1 | 2022 | 2622 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2016 | 5179 | 0.080 |
Why?
|
| Myosins | 1 | 2009 | 409 | 0.080 |
Why?
|
| Rhabditoidea | 1 | 2007 | 2 | 0.080 |
Why?
|
| Neoplasms | 3 | 2021 | 21683 | 0.080 |
Why?
|
| Photorhabdus | 1 | 2007 | 13 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2020 | 2538 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 12959 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2021 | 4445 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19229 | 0.050 |
Why?
|
| Adrenal Gland Diseases | 1 | 2020 | 138 | 0.040 |
Why?
|
| Urogenital Neoplasms | 1 | 2020 | 137 | 0.040 |
Why?
|
| Inpatients | 2 | 2021 | 2518 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 1708 | 0.040 |
Why?
|
| Humans | 10 | 2022 | 744343 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 251 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2017 | 203 | 0.040 |
Why?
|
| Aged | 4 | 2022 | 163280 | 0.040 |
Why?
|
| Mitochondria | 1 | 2009 | 3520 | 0.040 |
Why?
|
| Actins | 2 | 2017 | 2121 | 0.030 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2020 | 300 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2020 | 658 | 0.030 |
Why?
|
| Male | 5 | 2022 | 350118 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1663 | 0.030 |
Why?
|
| Myocarditis | 1 | 2020 | 771 | 0.030 |
Why?
|
| Dogs | 1 | 2017 | 3912 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2021 | 77449 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57776 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2017 | 3144 | 0.020 |
Why?
|
| Models, Biological | 1 | 2007 | 9583 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1678 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 63114 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2133 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3748 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
| Middle Aged | 4 | 2021 | 213383 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 2734 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
| Larva | 1 | 2007 | 519 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3690 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2007 | 295 | 0.020 |
Why?
|
| Symbiosis | 1 | 2007 | 287 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 3848 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 592 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3846 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2007 | 1402 | 0.010 |
Why?
|
| Female | 4 | 2021 | 380194 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10262 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16689 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5686 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 1703 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15997 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 72290 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 12072 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 168757 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 23403 | 0.000 |
Why?
|